Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.36 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.36 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.36 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | TK1 | P04183 | 3/20 | 0.34 |
| ▸ | DUT | P33316 | 1/20 | 0.33 |
| ▸ | TK2 | O00142 | 1/20 | 0.30 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3623796 | 1.00 | KIF11 (0.36) | KIF11PLA2G2APLA2G10PLA2G1BPLA2G5 | |
| SCHEMBL4763266 | 0.91 | DUT (0.40) | KIF11PLA2G2APLA2G10PLA2G1BPLA2G5 | |
| SCHEMBL5699551 | 0.91 | DUT (0.40) | KIF11PLA2G2APLA2G10PLA2G1BPLA2G5 | |
| SCHEMBL8687134 | 0.91 | KIF11 (0.39) | KIF11PLA2G2APLA2G10PLA2G1BPLA2G5 | |
| SCHEMBL4762320 | 0.89 | DUT (0.39) | KIF11PLA2G2APLA2G10PLA2G1BPLA2G5 | |
| SCHEMBL4762322 | 0.89 | DUT (0.39) | KIF11PLA2G2APLA2G10PLA2G1BPLA2G5 | |
| SCHEMBL4193339 | 0.88 | PLA2G2A (0.36) | KIF11PLA2G2APLA2G10PLA2G1BPLA2G5 | |
| SCHEMBL4200031 | 0.83 | KIF11 (0.33) | KIF11PLA2G2APLA2G10PLA2G1BPLA2G5 | |
| SCHEMBL12714267 | 0.80 | KIF11 (0.52) | KIF11CYP2C9ALOX15TSHRCYP2C19 | |
| SCHEMBL16854613 | 0.80 | PLA2G2A (0.50) | KIF11PLA2G2APLA2G10PLA2G1BPLA2G5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1341927-B1 | METHOD OF PREPARING 3-¬2-{(METHYLSULFONYL)OXY}ETHOXY|-4-(TRIPHENYLMETHOXY)-1-BUTANOL, METHANE SULFONATE | PPG IND OHIO INC (US) | 2006-08-02 | — | — | EP | claimed |
| EP-1341927-A1 | METHOD OF PREPARING 3- 2- (METHYLSULFONYL)OXY ETHOXY]-4-(TRIPHENYLMETHOXY)-1-BUTANOL, METHANE SULFONATE | PPG Industries Ohio, Inc. (US) | 2003-09-10 | — | — | EP | claimed |
| WO-2002059342-A1 | METHOD OF PREPARING 3-[2-{(METHYLSULFONYL)OXY}ETHOXY]-4-(TRIPHENYLMETHOXY)-1-BUTANOL, METHANE SULFONATE | PPG INDUSTRIES OHIO, INC. (US) | 2002-08-01 | — | — | WO | claimed |
| US-6300106-B1 | FORMING S-ISOMER OR R-ISOMER OF (3,6-DIHYDRO-2H-PYRAN-2-YL)-METHANOL VIA A PROCESS WHICH PRODUCES A RACEMIC MIXTURE OF INTERMEDIATE REACTION PRODUCTS, RESOLVING TO SELECTIVELY PRODUCE S ISOMER | PPG INDUSTRIES OHIO, INC. | 2001-10-09 | — | — | US | claimed |
| US-20260042778-A1 | Polymorphs of N-Desmethyl Ruboxistaurin and Salts Thereof | 4M THERAPEUTICS INC. (US) | 2026-02-12 | — | — | US | disclosed |
| EP-1341927-B1 | METHOD OF PREPARING 3-¬2-{(METHYLSULFONYL)OXY}ETHOXY|-4-(TRIPHENYLMETHOXY)-1-BUTANOL, METHANE SULFONATE | PPG IND OHIO INC (US) | 2006-08-02 | — | — | EP | disclosed |
| EP-1341927-A1 | METHOD OF PREPARING 3- 2- (METHYLSULFONYL)OXY ETHOXY]-4-(TRIPHENYLMETHOXY)-1-BUTANOL, METHANE SULFONATE | PPG Industries Ohio, Inc. (US) | 2003-09-10 | — | — | EP | disclosed |
| WO-2002059342-A1 | METHOD OF PREPARING 3-[2-{(METHYLSULFONYL)OXY}ETHOXY]-4-(TRIPHENYLMETHOXY)-1-BUTANOL, METHANE SULFONATE | PPG INDUSTRIES OHIO, INC. (US) | 2002-08-01 | — | — | WO | disclosed |
| WO-2002059342-A1 | METHOD OF PREPARING 3-[2-{(METHYLSULFONYL)OXY}ETHOXY]-4-(TRIPHENYLMETHOXY)-1-BUTANOL, METHANE SULFONATE | PPG INDUSTRIES OHIO, INC. (US) | 2002-08-01 | — | — | WO | disclosed |
| US-6300106-B1 | FORMING S-ISOMER OR R-ISOMER OF (3,6-DIHYDRO-2H-PYRAN-2-YL)-METHANOL VIA A PROCESS WHICH PRODUCES A RACEMIC MIXTURE OF INTERMEDIATE REACTION PRODUCTS, RESOLVING TO SELECTIVELY PRODUCE S ISOMER | PPG INDUSTRIES OHIO, INC. | 2001-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042778-A1 | Polymorphs of N-Desmethyl Ruboxistaurin and Salts Thereof | GSK3B, GSK3A, LRRK2 | KIF11 3811/4885PLA2G2A 4443/4885PLA2G10 4622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.